US advertising spend for prescription drugs declined 7.8% to $2.3 billion for the first six months of 2009 over the same period in 2008, according to TNS Media Intelligence data.
Wyeth is cranking up consumer advertising for Pristiq with spots that aim to capture depression sufferers’ struggle to get through the day, as represented by an iconic wind-up doll.
Last chance to grab glory
June 4, 2009
5:00 pm
If you still haven’t entered the MM&M Awards 2009, then you’d better move fast–today (June 5) is the final deadline for submissions.
DDMAC study: Serious risks in brief summary don’t scare off readers
The presence of information on serious side effects in the brief summaries of print DTC drug ads seems to have little effect on reader behavior, preliminary results of an FDA study show. The age and health literacy of readers, on the other hand, had a measurable impact.
Pharma US ad spend fell 18.4% in ’08, says Nielsen
Pharmaceutical industry ad spend fell 18.4% in 2008 to $4.3 billion in the US, according to The Nielsen Company. J&J, the sole drug company among the nation’s top 10 advertisers, spent $1.2 billion on advertising — a drop of 5.4% from 2007 spend.
Wyeth Consumer Health has launched a TV and print ad campaign for Advil advising consumers that they can do more with fewer bottles of OTC pain meds clogging up their purses, thanks to “The Every Pain Reliever.”
Print and TV ads for ED drugs should appear only in programs or publications with an adult audience of 90% or more under revised PhRMA consumer advertising guidelines — in the original version, released in August 2005, the baseline was 80% — and signatory company CEOs and chief compliance officers must sign an annual certification stating that they have policies and procedures in place to foster compliance with the principles.
DTC spend lags as firms scrimp on launches, says TNS
Spending on direct-to-consumer launch campaigns fell significantly this year as companies waited longer to market fewer new drugs with more limited indications, said a TNS Media Intelligence report.
All the fury over DTC drug ads emanating from Washington hasn’t dented their credibility with consumers, according to Rodale’s 11th Annual Survey on Consumer Reaction to DTC Advertising of Prescription Drugs.
